Test Price
2,800 AED✅ Home Collection Available
ARX Gene Mental Retardation, X‑Linked Type 29 Genetic Test in the UAE | 2800 AED | 2026 DHA Guidelines
تحليل الجينات ARX للإعاقة الذهنية المرتبطة بالكروموسوم X (النوع 29) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – UAE Trust & Precision
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑Certified Next‑Generation Sequencing (NGS) and clinically validated bioinformatics pipeline.
- Premium Logistics: Paid Hospital‑Grade Home Collection through ISO Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance with board‑certified genetic counsellors to interpret results in the context of your child’s full clinical picture.
- Insurance Support: Direct Billing Verification via WhatsApp +971 54 548 8731. Our team handles pre‑approval with all major UAE insurers.
فحص جيني دقيق ومعتمد يضمن أقصى درجات الأمان والدقة وفق المعايير الطبية الإماراتية الصادرة عن هيئة الصحة بدبي.
Comprehensive ARX Gene Analysis – Why It Matters
This advanced NGS‑based test examines the entire coding region of the ARX gene, the major cause of X‑linked intellectual disability type 29 (XLID29). It identifies pathogenic variants linked to intellectual disability, epilepsy, movement disorders and brain malformations – enabling a definitive molecular diagnosis, carrier detection for female relatives and informed genetic counselling. تسلسل جيني كامل وعميق يمنحك وضوحًا تشخيصيًا لا توفره الفحوصات التقليدية.
| Feature | Our ARX NGS Test | Closest Alternative (Microarray / Sanger) |
|---|---|---|
| Precision | Complete gene sequencing – detects point mutations, small indels, and splice variants with >99.9% analytical sensitivity | CMA misses intragenic point mutations; Sanger is limited to a few exons, often missing deep intronic variants |
| Methodology | NGS (Next‑Generation Sequencing) on Illumina platform with clinical‑grade bioinformatics | Chromosomal Microarray or single‑gene Sanger sequencing – lower resolution for gene‑specific mutations |
| Turnaround Time | 3 to 4 Weeks – backed by ISO‑certified Cold‑Chain logistics | Often 6–8 Weeks for comprehensive microarrays; bespoke Sanger panels can take longer |
| Price | 2800 AED – all‑inclusive, no hidden fees | 2500–4500 AED (variable, often excludes pre‑test genetic counselling) |
Physician Insight & Safety Protocol
“Every patient’s journey with intellectual disability is unique – this genetic test offers clarity but must be interpreted alongside a detailed neurological evaluation, family history and genetic counselling. I understand the emotional weight of such investigations and assure you we handle your child’s sample with the highest confidentiality and clinical rigour. A molecular diagnosis is the beginning of a personalised care plan, not an endpoint.”
— Dr. PRABHAKAR REDDY, Consultant Neurologist (DHA License: 61713011)
⚠ Medication Warning
Do not discontinue any prescribed medication without consulting your treating physician. Anti‑epileptic or neurodevelopmental drugs should be managed only under specialist supervision.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Active febrile illness, uncontrolled seizure within 24 hours, or known severe bleeding disorder. For children unable to tolerate venipuncture, a dried blood spot (FTA card) collection can be arranged – please inform the phlebotomist in advance.
- 🩸 Red Flags – seek immediate medical attention if: prolonged bleeding (>10 minutes), large haematoma, dizziness, or signs of infection (redness, warmth, pus) at the puncture site.
Pre‑Test Preparation: A genetic counselling session is mandatory before sample collection. We draw a detailed pedigree chart to document family members affected by intellectual disability, epilepsy or related neurodevelopmental disorders. No fasting is required. Please bring all relevant medical records (MRI reports, EEG, previous genetic reports) to the counselling appointment.
Frequently Asked Questions
1. What is the ARX Gene Mental Retardation, X‑Linked Type 29 Genetic Test?
This test uses next‑generation sequencing to detect mutations in the ARX gene responsible for X‑linked intellectual disability type 29, providing a molecular answer within 3–4 weeks. It covers all coding exons and flanking splice regions, delivering a definitive diagnosis when clinical suspicion is high – especially in boys with developmental delay, seizures or lissencephaly. The result empowers families with information about inheritance, prognosis and reproductive options.
ما هو اختبار الجينات ARX للإعاقة الذهنية المرتبطة بالكروموسوم X (النوع 29)؟
يستخدم هذا الفحص تقنية التسلسل الجيني من الجيل التالي لكشف الطفرات في جين ARX المسبّب للإعاقة الذهنية المرتبطة بالكروموسوم X من النوع 29، ويوفّر تشخيصًا جزيئيًا خلال 3 إلى 4 أسابيع. يغطي جميع الإكسونات والمناطق الحدودية، ويمنح العائلات توضيحًا حول الوراثة والتكهن والاختيارات الإنجابية.
2. Who should consider this test and how is it performed?
Any child or adult male with unexplained intellectual disability, early‑onset epilepsy, movement disorders such as dystonia, or brain imaging findings suggestive of lissencephaly should be offered ARX testing. Females with a family history of X‑linked intellectual disability may undergo carrier testing. The test requires a simple blood sample (1–2 mL in EDTA tube), extracted DNA or a dried blood spot on an FTA card; our certified phlebotomist performs the collection through the home‑collection service, strictly following cold‑chain protocols.
من هم المرشحون لهذا الفحص وكيف يتم إجراؤه؟
يُنصح به لأي طفل أو بالغ ذكر يعاني من إعاقة ذهنية غير مفسّرة، نوبات صرع مبكرة أو تشوهات دماغية. ويمكن للإناث الحاملات إجراء فحص الناقل. تُسحب العينة من الدم أو بطاقة FTA خلال زيارة منزلية تحت سلسلة تبريد معتمدة.
3. What do the results mean and what are the next steps?
A positive (pathogenic) result confirms the clinical diagnosis, clarifies prognosis, and enables cascade testing of at‑risk relatives. A negative result does not rule out other genetic causes; your neurologist may recommend broader gene panels or whole exome sequencing. All results are discussed in a dedicated post‑ telehealth session with a clinical geneticist. Based on the result, early intervention (speech, physical therapy) and family planning can be optimised.
ماذا تعني النتائج وما هي الخطوات التالية؟
النتيجة الإيجابية تؤكد التشخيص وتسمح بفحص الأقارب المعرضين. أما السلبية فلا تنفي الأسباب الجينية الأخرى. تُناقَش جميع النتائج في جلسة استشارة عن بُعد مع أخصائي الوراثة، ويُوضَع خطة تدخّل مبكر وتنظيم أسري حسب الحاجة.
UAE Regulatory & Quality Compliance
- All genetic testing is performed in accordance with Federal Decree‑Law No. 41 of 2024 (Art. 87) – safeguarding genetic data privacy and requiring informed consent.
- Testing for minors complies with the UAE Child Data Safety (CDS) Law 2026, requiring parental/guardian authorisation and mandatory genetic counselling.
- Patient data handling follows the UAE Personal Data Protection Law (PDPL), ensuring encryption, restricted access and strict confidentiality.
- ISO 9001:2015 Certified Facility – Cert: INT/EGQ/2509DA/3139; DHA/MOHAP Facility License: 9834453.
- Clinical validity maintained through regular proficiency testing and adherence to CAP/CLIA-equivalent standards.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians